Why Alector Shares Are Diving Today
Having dropped from the lofty heights it reached only a few short months ago, Alector (NASDAQ: ALEC) stock was having another bad day on Wednesday. The biotech's shares were down nearly 17% in mid-afternoon trading following some news from the C-suite.
After market hours on Tuesday, Alector announced the departure of two high-level executives. It said that chief operating officer Shehnaaz Suliman and chief medical officer Robert Paul will step down following a "transition period," and should continue to serve as advisors to the company until the end of this year.
Image source: Getty Images.
Source Fool.com
